A detailed history of Engineers Gate Manager LP transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 11,294 shares of CRBU stock, worth $13,101. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,294
Holding current value
$13,101
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.59 - $2.79 $17,957 - $31,510
11,294 New
11,294 $17,000
Q4 2022

Feb 14, 2023

BUY
$5.57 - $11.01 $71,301 - $140,939
12,801 New
12,801 $80,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $70.6M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.